Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Garcia-Cao I, Lafuente MJ, Criado LM, Diaz-Meco MT, Serrano M, Moscat J. Genetic inactivation of Par4 results in hyperactivation of NF-kappaB and impairment of JNK and p38. EMBO Rep. 2003;4(3):307-12.

Chadburn A, Narayanan S. Lymphoid malignancies: immunophenotypic analysis. Adv Clin Chem. 2003;37:293-353.

Allen EA, Parwani AV, Siddiqui MT, Clark DP, Ali SZ. Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol. 2003;47(2):183-7.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, et al. Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003;21(16):3051-9.

Magro CM, Ross P, Kelsey M, W Waldman J, Pope-Harman A. Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant. 2003;3(9):1155-66.

Barbareschi M, Murer B, Colby TV, Chilosi M, Macrì E, Loda M, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. 2003;27(2):141-9.

Feldman E, Najfeld V, Schuster M, Roboz G, Chadburn A, Silver RT. The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate. Exp Hematol. 2003;31(8):702-7.

Larcher B, Arisi E, Berloffa F, Demichelis F, Eccher C, Galligioni E, et al. Analysis of user-satisfaction with the use of a teleconsultation system in oncology. Med Inform Internet Med. 2003;28(2):73-84.

Porcu P, Baiocchi RA, Magro C. Recent developments in the biology and therapy of T-cell and natural killer-cell lymphomas. Curr Opin Oncol. 2003;15(5):353-62.

Fournier E, Isakoff SJ, Ko K, Cardinale CJ, Inghirami GG, Li Z, et al. The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr Biol. 2003;13(21):1858-66.